OC-3（OneChain Immunotherapeutics）

N/A

Report date: 2023/02/10 15:16:55

Base Information

Drug NameOC-3（OneChain Immunotherapeutics）
Drug Alias NameOC-3
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionImmunologic cytotoxicityT lymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOnechain Immunotherapeutics SL
China Registration ClassN/A

Develop Information

Active CompaniesOnechain Immunotherapeutics SL
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A